Literature DB >> 12944553

Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories.

M A Piens1, J D Perry, H Raberin, F Parant, A M Freydière.   

Abstract

AIMS: To evaluate the rapid identification of Candida glabrata using a one minute trehalase and maltase test in four clinical laboratories.
METHOD: The test was evaluated with 944 freshly isolated yeasts comprising 572 C glabrata and 372 non-C glabrata strains. These strains were isolated on one of three differential media-Candida ID, CHROMagar Candida, or Albicans ID2 medium-and all strains were fully identified using standard methods.
RESULTS: The trehalase and maltase test allowed the overall identification of 550 of 572 C glabrata strains (sensitivity, 96.2%) and only 11 of 372 isolates of other yeast species yielded a false positive result (specificity, 96.8 %). Sensitivity and specificity were consistent from one laboratory to another. Using Candida ID medium, the rapid trehalase and maltase test showed a sensitivity of 95% and specificity of 96.2%. Using CHROMagar Candida, sensitivity and specificity were 95.6% and 98.1%, respectively. Using Albicans ID2 medium (tested by two laboratories), the sensitivity was 100% and 98.5% and specificity was 98.1% and 98.2%. In 60% of cases, the test could be performed directly from the primary isolation medium, thus reducing the time for identification.
CONCLUSION: The rapid trehalase and maltase test was highly reliable for the presumptive identification of C glabrata on primary isolation using three different chromogenic media. Direct recognition of C albicans by means of their characteristic colour on chromogenic media coupled with one minute trehalase maltase testing performed only on suspect colonies of C glabrata allowed for rapid presumptive identification of the two yeast species most commonly encountered in clinical samples.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944553      PMCID: PMC1770057          DOI: 10.1136/jcp.56.9.687

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Rapid identification of Candida species by confocal Raman microspectroscopy.

Authors:  K Maquelin; L P Choo-Smith; H P Endtz; H A Bruining; G J Puppels
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Yeast identification in the clinical microbiology laboratory: phenotypical methods.

Authors:  A M Freydiere; R Guinet; P Boiron
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

3.  Evaluation of a reformulated CHROMagar Candida.

Authors:  M A Jabra-Rizk; T M Brenner; M Romagnoli; A A Baqui; W G Merz; W A Falkler; T F Meiller
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates.

Authors:  C Baumgartner; A M Freydiere; Y Gille
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

6.  Performance of candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida.

Authors:  B Willinger; C Hillowoth; B Selitsch; M Manafi
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Comparison of four methodologies for rapid and cost-effective identification of Candida glabrata.

Authors:  J P Fenn; E Billetdeaux; H Segal; L Skodack-Jones; P E Padilla; M Bale; K Carroll
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species.

Authors:  H Fricker-Hidalgo; S Orenga; B Lebeau; H Pelloux; M P Brenier-Pinchart; P Ambroise-Thomas; R Grillot
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

9.  Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period.

Authors:  M F Price; M T LaRocco; L O Gentry
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.

Authors:  F C Odds; R Bernaerts
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

View more
  4 in total

Review 1.  Biology of the pathogenic yeast Candida glabrata.

Authors:  A Bialková; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

2.  Evaluation of the commercial rapid trehalose test (GLABRATA RTT) for the point of isolation identification of Candida glabrata isolates in primary cultures.

Authors:  Mark Fraser; Andrew M Borman; Elizabeth M Johnson
Journal:  Mycopathologia       Date:  2012-01-11       Impact factor: 2.574

3.  Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol.

Authors:  Michael Gherna; William G Merz
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

4.  Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

Authors:  A M Freydiere; J D Perry; O Faure; B Willinger; A M Tortorano; A Nicholson; J Peman; P E Verweij
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.